The Boston-based company secured backing from existing investors and new investors, including Affinity Asset Advisors, Dimension Capital, Jeito Capital, Lightspeed Ventures, TPG Life Sciences Innovations, and Wedbush Healthcare The post Odyssey Therapeutics raises $213m via Series D appeared first on Pharmaceutical Business review.